Lexeo Therapeutics, Inc. (LXEO)

CIK 1907108 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Lexeo Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 4, 2026EFFECT9999999995-26-003444
Oct 29, 2026S-30001193125-26-437001
Oct 13, 2026SCHEDULE 13G0000019617-26-000349
Sep 29, 20268-K0001193125-26-407555
Sep 28, 202640002024096-26-000015
Sep 28, 202640002109299-26-000009
Sep 28, 202640001995218-26-000017
Sep 28, 202640002083206-26-000009
Sep 22, 20268-K0001193125-26-397221
Aug 19, 202640001995218-26-000015
Aug 19, 202640002083206-26-000007
Aug 19, 202640002024096-26-000013
Aug 18, 20261440001959173-26-006154
Aug 18, 20261440001959173-26-006153
Aug 18, 20261440001959173-26-006152
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003428
Aug 14, 2026SCHEDULE 13G0000947871-26-000801
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097207
Aug 13, 2026SCHEDULE 13G/A0001011438-26-000515
Aug 12, 202610-Q0001193125-26-345724
Aug 12, 20268-K0001193125-26-345722
Aug 7, 2026SCHEDULE 13G0000093751-26-000489
Jul 1, 202640002083206-26-000005
Jul 1, 202640002109299-26-000007
Jul 1, 20261440001959173-26-005031